ABBOTT LABORATORIES
Customers
7
5 federal agencies, 2 prime contractors
Suppliers
1
1 disclosed
Federal obligations
$44.8M
FY2027 · USAspending.gov
Latest period
Dec 31, 2025
10-K filed 2026-02-23
Suppliers 1
Companies that disclose ABT as a major customer, as a share of their own revenue. 1 active, 0 lapsed.
| Company | % of their revenue | Est. $ from ABT | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| ITGR Integer Holdings Corp |
Named | — | FY 2025-12-31 | — | Active | 10-K 2026-02-23 |
During 2025, three of our customers, Abbott Laboratories, Boston Scientific and Medtronic were each in excess of 10% of total sales and collectively accounted for 49% of our total sales. | ||||||
Federal contracts 5
Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $92.8M in the latest fiscal year shown per agency.
| Agency | Obligated | Fiscal year | Awards | Trend | Largest award |
|---|---|---|---|---|---|
| Department of Veterans Affairs
Department of Veterans Affairs |
$44.8M | FY 2027 | 110 | $101.5M → $70.7M → $92.8M → $102.6M → $44.8M | 36C26127N0094 |
EXERCISE ORDERING PERIOD | |||||
| Department of Health and Human Services
Office of Assistant Secretary for Preparedness and Response |
$23.9M | FY 2026 | 47 | $261.7M → $3.1M → $22.0M → $23.9M | 75A50122C00046 |
ABBOTT: TO CONDUCT CLINICAL TRAINING AND VALIDATION STUDIES TO SUPPORT A FUTURE FDA MARKETING APPLICATION WITH AN EXPANDED INDICATION FOR USE OF THE ABBOTT TBI TEST ? TO AID IN THE DIAGNOSIS OF TRAUMATIC BRAIN INJURY IN ADULTS AND PEDIATRIC PATIENTS. | |||||
| Department of Defense
Washington Headquarters Services |
$20.6M | FY 2026 | 2,797 | $28.5M → $28.6M → $27.8M → $20.6M | HQ003425C0015 |
CIVILIAN DRUG FREE WORKPLACE COLLECTIONS AND MEDICAL REVIEW SUPPORT SERVICES. | |||||
| Department of the Interior
Departmental Offices |
$2.4M | FY 2026 | 5 | $2.2M → $2.8M → $1.4M → $2.4M | 140D0426F0156 |
HRD-26-062 PEMBROOKE 4/1/26-3/31/27 | |||||
| Department of Justice
Federal Prison System / Bureau of Prisons |
$1.2M | FY 2026 | 18 | $2.2M → $2.0M → $2.2M → $1.2M | 15B10626F00000065 |
CHEMISTRY ANALYZER EQUIPMENT AND SUPPLIES TO BE RENDERED IN ACCORDANCE WITH THE BPA 15B10621A00000284 OPTION YEAR 4 DOS: DECEMBER 1, 2025- CR JANUARY 30, 2026 | |||||
Federal subcontracts received 2
Prime contractors that subcontracted federal work to this company. From USAspending.gov subaward reports; amounts are as reported by the prime contractor, latest report per subaward, $500K+ a year.
| Company | Subawards | Fiscal year | Count | Trend | Largest subaward |
|---|---|---|---|---|---|
| Chemonics International, INC. | $10.3M | FY 2025 | 4 | AIDOAATO1500007 | |
THE PRIMARY PURPOSE OF THIS BOA IS TO ESTABLISH THE BASIC TERMS AND CONDITIONS FOR THE PURCHASE OF HEALTH COMMODITIES. THIS BOA IS GENERALLY DIVIDED INTO TWO PARTS: (1) THE MASTER BOA THAT ESTABLISHES TERMS AND CONDITIONS ACROSS HEALTH COMMODITY GROUPS AND (2) THE PRICE SCHEDULE ANNEX AND/OR COMMODITY GROUP ANNEX(ES) (ANNEX), PERIODICALLY NEGOTIATED UNDER THIS BOA, THAT ESTABLISH COMMODITY GROUP SPECIFIC TERMS AND CONDITIONS, SUPPLIER QUALIFICATION REQUIREMENTS, PRODUCT DETAILS, PRICING, AND ALLOCATION METHODOLOGIES. THE PRIMARY COMMODITY COVERED BY THIS BOA ARE VARIOUS RAPID DIAGNOSTIC TESTS AND REAGENT/CONSUMABLE KITS FOR DIAGNOSTIC ANALYZERS. | |||||
| Cardinal Health 200, LLC | $588.6K | FY 2025 | 13 | SPE2DM25FVNML | |
MEDICAL/SURGICAL EQUIPMENT OR SUPPLIES | |||||
Alerts are coming
Get an email when ABT's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.